mirtazapine has been researched along with Alice in Wonderland Syndrome in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Alice in Wonderland Syndrome: Neurological condition characterized by disturbances in VISUAL PERCEPTION, most often of BODY SCHEMA, TIME PERCEPTION and HALLUCINATIONS. It is associated with MIGRAINE, infections (e.g., INFECTIOUS MONONUCLEOSIS), FEVER, EPILEPSY, and other neurological and psychiatric disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yrondi, A | 1 |
| Schmitt, L | 1 |
| Arbus, C | 1 |
1 other study available for mirtazapine and Alice in Wonderland Syndrome
| Article | Year |
|---|---|
["Alice in wonderland syndrome", a precursor of depressive disorder with melancholic characteristics].
Topics: Aged; Alice in Wonderland Syndrome; Antidepressive Agents, Second-Generation; Antimanic Agents; Comb | 2017 |